Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assessment of the drug metabolism capacity of the liver.

× No keyword cloud information.

194 in total

1. The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors: E S Vesell
Journal: Clin Pharmacol Ther Date: 1979-09 Impact factor: 6.875

2. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors: E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal: Clin Pharmacol Ther Date: 1975-09 Impact factor: 6.875

3. THE ROLE OF GAMMA-GLUTAMYL TRANSPEPTIDASE IN THE INTERNAL DISEASES CLINIC.

Authors: M ORLOWSKI
Journal: Arch Immunol Ther Exp (Warsz) Date: 1963 Impact factor: 4.291

4. 6beta-Hydroxycortisol and other polar corticosteroids: measurement and significance in human urine.

Authors: A G FRANTZ; F H KATZ; J W JAILER
Journal: J Clin Endocrinol Metab Date: 1961-10 Impact factor: 5.958

5. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.

Authors: D Perrier; M Gibaldi
Journal: J Pharmacol Exp Ther Date: 1974-10 Impact factor: 4.030

6. Differential effects of enzyme induction on antipyrine metabolite formation.

Authors: M Danhof; R M Verbeek; C J van Boxtel; J K Boeijinga; D D Breimer
Journal: Br J Clin Pharmacol Date: 1982-03 Impact factor: 4.335

7. Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings].

Authors: A T Birmingham; A J Coleman; M L Orme; B K Park; N J Pearson; A H Short; P J Southgate
Journal: Br J Clin Pharmacol Date: 1978-11 Impact factor: 4.335

8. Rat and human liver microsomal epoxide hydratase. Purification and evidence for the existence of multiple forms.

Authors: F P Guengerich; P Wang; M B Mitchell; P S Mason
Journal: J Biol Chem Date: 1979-12-10 Impact factor: 5.157

9. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors: M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal: Eur J Clin Pharmacol Date: 1979-09 Impact factor: 2.953

10. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.

Authors: J P Miguet; P Mavier; C J Soussy; D Dhumeaux
Journal: Gastroenterology Date: 1977-05 Impact factor: 22.682

30 in total

1. Interaction between vigabatrin and phenytoin.

Authors: E M Rimmer; A Richens
Journal: Br J Clin Pharmacol Date: 1989 Impact factor: 4.335

2. Ifosfamide plasma clearance in relation to polymorphic debrisoquine oxidation.

Authors: P A Philip; L D Lewis; C A James; H J Rogers
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

3. Cisapride has no effect on antipyrine clearance.

Authors: D S Davies; F J Mills; P J Welburn
Journal: Br J Clin Pharmacol Date: 1988-12 Impact factor: 4.335

4. Antipyrine clearance and metabolism in patients with psoriasis.

Authors: K Kubota; T Ishizaki; K Chiba; A Takagi; A Nakagawa; K Nakamura
Journal: Br J Clin Pharmacol Date: 1986-10 Impact factor: 4.335

5. D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.

Authors: G Heinemeyer; I Roots; P Lestau; H R Klaiber; R Dennhardt
Journal: Br J Clin Pharmacol Date: 1986-01 Impact factor: 4.335

Review 9. Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives.

Authors: M Døssing
Journal: Int Arch Occup Environ Health Date: 1984 Impact factor: 3.015

10. Effect of the removal of individual antiepileptic drugs on antipyrine kinetics, in patients taking polytherapy.

Authors: P N Patsalos; J S Duncan; S D Shorvon
Journal: Br J Clin Pharmacol Date: 1988-09 Impact factor: 4.335

Assessment of the drug metabolism capacity of the liver.